August 25, 2017

Insys To Pay $4.45M To Illinois, Agrees To Restrict Opioid Marketing

CHICAGO — Insys Therapeutics Inc. on Aug. 17 agreed to pay $4.45 million to Illinois and agreed to restrictions on how it markets its opioid drugs in the state, according to a final judgment and consent decree in the state’s consumer fraud lawsuit against the drug maker in Illinois state court (Illinois v. Insys Therapeutics, Inc., No. 2016-CH-11216, Ill. Cir., Cook Co.).